| Literature DB >> 28251067 |
Vasileios S Nikolaou1, Michael-Alexander Malahias1, Maria-Kyriaki Kaseta1, Ioannis Sourlas1, George C Babis1.
Abstract
AIM: To investigate the effectiveness of ultrasound-guided release of the first annular pulley and compare results with the conventional open operative technique.Entities:
Keywords: A1 release; Comparative; Minimally-invasive; Percutaneous; Trigger finger; Ultrasound-guided; V-lance knife
Year: 2017 PMID: 28251067 PMCID: PMC5314146 DOI: 10.5312/wjo.v8.i2.163
Source DB: PubMed Journal: World J Orthop ISSN: 2218-5836
Figure 1Longitudinal view of the middle finger’s flexor tendons (white arrows) volarly to the metacarpal-phalangeal joint (blue double arrow). The A1 pulley appears swollen and anechoic (yellow arrows), establishing the trigger finger disease.
Figure 2Positioning of the V-Lance Knife almost parallel to the probe.
Figure 3Longitudinal ultrasound-guided release of the A1 pulley. The knife -with its acoustic shadowing (green arrows) - is clearly visible (white arrows). Its tip is advanced over the metacarpal-phalangeal joint (yellow arrow), parallel to the superficial flexor tendon.
Figure 4In order to be assured for the right position of the knife, we are transferred in transverse view of the tendons (flexor’s transverse cut: Yellow arrows, lying on the bone: Light blue arrow). Here, we certify that the tip of the knife (tip as a white dot: white arrows, sending its characteristic acoustic shadow: Green arrows) is attaching the volar end of the tendons (without penetrating them), under the A1 pulley (the sheath is appeared as a thin line under the red arrows). Moreover, it is vital to avoid the neurovascular digital structures (digital artery in the curved side of the purple moon).
Group A, data per patient: Days for: (1) taking pain killers; (2) returning to normal activities; (3) complete extension; and (4) flexion recovery
| Patient 1 | 4 | 3 | 8 | 4 |
| Patient 2 | 7 | 8 | 9 | 5 |
| Patient 3 | 1 | 2 | 3 | 1 |
| Patient 4 | 5 | 6 | 5 | 3 |
| Patient 5 | 1 | 3 | 6 | 2 |
| Patient 6 | 2 | 2 | 5 | 0 |
| Patient 7 | 3 | 2 | 7 | 6 |
| Patient 8 | 5 | 4 | 10 | 7 |
| Patient 9 | 0 | 2 | 4 | 1 |
| Patient 10 | 1 | 2 | 8 | 4 |
| Patient 11 | 6 | 10 | 12 | 7 |
| Patient 12 | 1 | 0 | 5 | 2 |
| Patient 13 | 3 | 3 | 6 | 5 |
| Patient 14 | 4 | 4 | 11 | 5 |
| Patient 15 | 10 | 8 | 7 | 5 |
| Patient 16 | 3 | 6 | 9 | 6 |
| Total | 56 | 65 | 115 | 63 |
| Mean | 3.5 | 4.1 | 7.2 | 3.9 |
Figure 5The Q-DASH fluctuation per patient in (A) and (B) respectively.
Group B, data per patient: days for: (1) taking pain killers; (2) returning to normal activities; (3) complete extension; and (4) flexion recovery
| Patients 1 | 5 | 23 | 7 | 3 |
| Patients 2 | 0 | 15 | 5 | 4 |
| Patients 3 | 2 | 14 | 1 | 1 |
| Patients 4 | 1 | 15 | 3 | 1 |
| Patients 5 | 3 | 17 | 11 | 4 |
| Patients 6 | 3 | 15 | 4 | 3 |
| Patients 7 | 4 | 21 | 8 | 4 |
| Patients 8 | 6 | 22 | 9 | 5 |
| Patients 9 | 0 | 14 | 1 | 1 |
| Patients 10 | 2 | 18 | 6 | 3 |
| Patients 11 | 5 | 18 | 6 | 5 |
| Patients 12 | 1 | 16 | 2 | 2 |
| Patients 13 | 6 | 23 | 16 | 3 |
| Patients 14 | 4 | 22 | 4 | 3 |
| Patients 15 | 3 | 17 | 2 | 4 |
| Patients 16 | 1 | 15 | 5 | 2 |
| Total | 46 | 285 | 90 | 48 |
| Mean | 2.9 | 17.8 | 5.6 | 3 |
Figure 6Regarding the cosmetic results, there is a clear difference between the two groups, in favor of the ultrasound-treated patients.